Jones Financial Companies’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.1K Buy
8,831
+360
+4% +$845 ﹤0.01% 3352
2025
Q4
$23K Buy
8,471
+3,000
+55% +$9.85K ﹤0.01% 2873
2025
Q3
$22.1K Buy
5,471
+2,416
+79% +$10.6K ﹤0.01% 2744
2025
Q2
$15K Buy
3,055
+468
+18% +$2.03K ﹤0.01% 2717
2025
Q1
$11.6K Hold
2,587
﹤0.01% 2644
2024
Q4
$12K Buy
2,587
+100
+4% +$550 ﹤0.01% 2451
2024
Q3
$17K Buy
+2,487
New +$19.5K ﹤0.01% 2014

Other funds holding GDRX

Jones Financial Companies's GDRX Position: Q1 2026 in Review

Jones Financial Companies increased its GoodRx Holdings (GDRX) stake by 4.2% in Q1 2026, buying an estimated $845 and bringing the position to 8,831 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3352.

Jones Financial Companies first reported a position in GDRX in Q3 2024 and has held it in 7 quarters since. The position peaked at $23K in Q4 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Jones Financial Companies held 8,831 shares of GoodRx Holdings worth $17.1K as of Q1 2026.
  • Jones Financial Companies bought 360 GoodRx Holdings shares in Q1 2026, an estimated $845.
  • GoodRx Holdings made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3352 holding.
  • Jones Financial Companies first reported a position in GoodRx Holdings in Q3 2024 and has held it in 7 quarters since.
  • Jones Financial Companies's GoodRx Holdings position peaked at $23K in Q4 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.